We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00112502
Recruitment Status : Completed
First Posted : June 3, 2005
Last Update Posted : September 25, 2014
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center